- Atlas’ $400M growth fund will support its portfolio of biotechs FirstWord Pharma
- Atlas Venture Announces $400 Million Third Opportunity Fund Business Wire
- VC Atlas lands $400M to support existing biotech portfolio Fierce Biotech
- Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound statnews.com
- Atlas Venture reels in $400M to grow its biotech startups BioPharma Dive
The wire
More investor news
Spanish VC Seaya Enters London After Raising €600 Million – Bloomberg.com
Battle for talent sparks growing interest in tender offers – PEI Private Equity
Barcelona’s Masia closes €18 million debut fund and opens a physical hub for frontier tech founders and investors – EU-Startups
US fintech Whop lands $200m Series D at $5.1bn valuation – FinTech Futures
Raynal leaves corporate VC role at EDF to join energy startup – Global Venturing
Warhound raises $200M to engineer war dogs and arm them with Anduril gear – TechCrunch Venture